Skip to content
Search

Latest Stories

'Peace of mind to pharmacists and their patients': Teva updates packaging across generics portfolio

Teva UK has begun replacing its existing packaging with a new design which is "clearer and easier to read".

The new look is "unique, recognizable and distinctive." It "enhances safety and provides a recognizable and distinguishable pack range."


One of the UK’s leading generics manufacturers, Teva UK supplies more than 500 generic pharmaceutical products to retail and hospital pharmacies.

The company says each product within the portfolio is distinguishable by color, ensuring no two different packs have the same drug and strength colors and with additional product information on the side of the pack and a simplified back, it makes it even easier to identify the correct product when dispensing and supports patients when taking their medication.

“Our medicines impact the lives of millions of people every day and our packaging is often the first touchpoint for our patients and our customers”, said Kim Innes, general manager of Teva UK and Ireland.

“We’ve updated our packaging with the dispensing process and patients in mind making packs clearer and easier to read, ensuring no two packs have the same drug and strength color, bringing peace of mind to pharmacists and their patients.”

In 2006, Teva introduced packaging designed with the end user in mind, making products on the shelf easier to distinguish and dispense. The new design, the company said, builds on this work and have been produced following extensive consultation with more than 4,000 healthcare professionals, patients and carers from around the UK and the rest of the world, as well as spending hundreds of hours engaging with our regulatory authorities.

Pharmacists can experience the pack and see the thinking behind our design changes using augmented reality by scanning a QR code which can be found across all related packaging launch materials.

The company added: "The new packaging will be applied across our whole generics portfolio, helping people understand our wider range of products and will be moved onto branded and OTC lines over the course of 2023."

More For You

Cargo plane unloading pharmaceuticals at US airport amid tariff concerns and stockpiling

Imports jumped in particular from Ireland, the top drug exporter to the US

Pic credit: iStock

Pharma imports to US surged in March as drugmakers look to avoid tariffs

Pharmaceutical imports to the US surged in March as drugmakers stocked up ahead of potential US tariffs on their products, which have historically been exempt from such fees.

Total imports of pharmaceutical products exceeded $50 billion in the month - the equivalent of 20 per cent of all pharmaceutical imports in 2024, according to data from a U.S. Commerce Department report on Tuesday.

Keep ReadingShow less
Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less